Show Summary Details
(p.477) Subject Index
(p.477) Subject Index
age-related macular degeneration 135
amoebiasis 225
antibacterial coatings 265
anticancer implants 269
apoferritin 32
arsenic 53, 121, 126, 135, 139, 144, 175, 176, 191, 195, 229, 236, 272, 276, 297, 302
DALYs 274
obesogenicity 192
Salvarsan 161
arsenobetaine 229
atherosclerosis 182
automotive 287
Azotobacter vinelandii 54
Bacillus subtilis 78
bacterial metal homeostasis, mechanisms of 57–82
bipolar disorder 201
blackfoot disease 135
(p.478)
body fluids, metalloproteomics of 344–348
breastfeeding. See nursing
cadmium 140, 173, 175–177, 192, 195, 205, 229, 272, 277, 294, 302, 330, 364
epigentic effects 292
interaction with arsenic 236
resistance 51
toxicity 95
calcitonin 194
cancer 130, 133, 135, 137, 144–146, 149, 173, 182, 200, 258
chronic myeloid leukemia 174
role of selenium 231
carotenoids 195
Caulis Spatholobi 96
cell lystates, metalloproteomics of 344–348
chromium 14, 126, 136, 143, 144, 174, 175, 200, 201, 231, 258, 287, 301
epigentic effects 292
RDA 126
cigarette smoking. See smoking
competition 2, 4, 13, 17, 25, 40, 42, 78, 101, 201, 202, 271
in vivo experiments 116
microbal 29–38
role of the host 117
thermodynamic 105
(p.479)
copper 45, 57, 59, 72–76, 87, 125, 138, 144, 166, 173, 192, 200, 214–216, 225, 287, 301, 355
content in E. coli 41
cytotoxicity 258
relative bioavailability 93
Corynebacteria 64
coxsackievirus B468 188
Crohn disease 151
cryo-ultramicrotomy 324
cytoplasmic metal export 50–53
dental caries 284
differential washout 334–335
divalent metal-binding protein 59–62
dyspepsia 141
Ebola 138
electron absorption techniques 323
element imaging 323–340
Enterobacter cloacae 261
Enterococcus faecalis 261
Escherichia coli 43, 44, 57, 60, 64–66, 74, 119, 120, 139, 261, 302, 305, 315, 316
metal usage by 58–65
nanotherapy 293
Zn resistant 79
essential metals 1, 3, 14–19, 27, 38, 39, 45, 78, 83, 94, 125–135, 142–146, 148, 199, 200, 201–205
classification of 231
coexposure to toxic metals 4
upper intake levels 87–92
flavonoids 195
fluorescence-based sensors 354–360
fluorescence resonance energy transfer (FRET) 353
fluorescence spectroscopy 377
fluorimetric techniques 342
Friedreich’s ataxia 130
future research 5, 6, 19, 27, 28, 38, 46, 55, 56, 82, 112, 115, 117, 120, 121, 143, 168, 170, 172, 215, 242, 255, 273, 291, 297–300, 374–377
Gram-negative bacteria 21, 27, 32, 50, 51, 52, 156, 261, 301–304
impact of silver 259
metal transport 22
homeostasis 13–19, 27, 103, 230
adaptable nature of 43
during development 125–146
mechanisms of bacterial metal 57–82
modeling of 372
host defense 2, 3, 8, 32, 46, 118, 154, 203, 208, 211, 242, 276, 279, 282, 295, 301–307. See also host tolerance, nutritional immunity
role of cobalt 139
role of copper 215
role of selenium 223
human development 125–146
hyperkeratosis 135
hypocalcaemia 259
immune response 2, 3, 147–160, 186, 207, 211, 214, 223, 284, 304
gender differences 285
implants 266–268
role of leptin 196
inductively coupled plasma mass spectrometry (ICP-MS) 8, 41, 102, 311, 313, 342–344
laser ablation 323–326
infectobesity 188
(p.482)
inner electron shell transitions 328–332
iron 15, 44, 59, 61–68, 79, 125, 145, 200, 203, 207–215, 276, 301, 330, 355
avoiding deficiency 63–66
content in E. coli 41
metabolism in inflammation 149–152
relative bioavailability 93
role in cell plasticity 148–149
tolerable upper intake levels 89
Japan National Study on Children and the Environment 277
ketoconazole 164
KNHANES studies 277
lactation. See nursing
Lactobacillus sakei 327
leprosy 139
leptospirosis 285
leukocytosis 130
life cycle assessment 251
lipidomics 296
liquid chromatography (LC) 34, 345, 346
electrospray ionization-mass spectrometry (ESI-MS) 312
reversed phase 347
malaria 2, 4, 6, 139, 152, 154, 161–163, 172, 185, 200, 208, 210, 271, 287, 288, 296, 373
chemotherapy 169
new vaccine 169
manganese 15, 32, 46, 55, 57, 59, 65, 79, 125, 130, 131, 145, 174, 180, 200, 202, 205–207, 302
bioavailability 93
chemical properties 68–71
content in E. coli 41
deficiency 206
export 19
in infant formulas 290
overloading 120
RDA 126
restriction 119
SitABCD/YfeABCD 111
starvation 158
supplementation 145
mass spectrometry 299
melanin 114
mercury 50, 52, 94, 126, 135, 140, 174, 192, 195, 205, 272, 277, 297, 302
relationship to malaria 275
metal availability 5, 57, 58, 71, 99, 100–106, 113, 200
measuring 112
microbiota influence 117–119
modeling 103
metal–metal interaction 94–96
metal storage. See storage
(p.484)
metal toxicity. See toxicity
metal uptake. See uptake
Minamata disease 94
mitochondrial respiration 148
molybdenum 14, 17, 49, 54, 55, 125, 132, 138, 145, 173, 180, 181, 204, 205, 280, 303, 316
content in E. coli 41
Mycobacterium abscessus 188
nephrotoxicity 240
nickel 25, 42–45, 54, 126, 136, 137, 145, 173, 181, 200, 205, 231, 287, 303
content in E. coli 41
epigentic effects 292
NMR spectrometers 375
nonredox-active metals 15
nutrition 1, 50, 84, 92, 125, 141, 142, 277, 281, 404. See also diet, recommended dietary allowances (RDAs)
hidden hunger 280
oxidative stress 37, 63, 67, 71, 79, 80, 137, 157, 171, 176, 185, 186, 190–192, 195, 204, 223, 229, 234, 236, 259
pathogenesis of infectious disease 1, 5, 6, 9, 118, 185, 222, 271, 273, 277, 286, 297, 372
obesity-related 191
plant extracts 96
platinosis 240
polymer coatings 263
preinfection metal exposure 113–116
reference dose (RfD) 278
resistance-nodulation-cell division (RND) 51
retinal disease 130
(p.486)
scanning electron microscopy energy dispersive X-ray analysis (SEM-EDX) 323, 331, 333, 378, 382
selenium 94, 125, 132, 146, 173, 183, 199, 200, 205, 231–233, 297, 299, 303
coatings 265
relative bioavailability 93
role in viral infections 222
sickle cell anemia 373
sleeping disease 225
Staphylococcus aureus 32, 37, 43, 115, 139, 178, 187, 188, 223, 261, 263, 294, 305, 363
nanotherapy 293
Streptomyces coelicolor 78
stroke 182
terbium 307
3D atlas 323
tobacco. See smoking
trace metals
homeostasis 186
transcription factors 15, 57, 60, 63, 66–69, 74, 77, 100, 148, 154, 155, 211, 213, 218, 221, 266, 377
trioxaquines 171
tropical parasitic illnesses 161–172
ultra-microtomy 324
uropathogenic E. coli (UPEC) 52
whole body imaging 374
yellow fever 288